LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China · Delayed Price · Currency is CNY 14.49
-0.11 (-0.75%)
Oct 29, 2026, 3:00 PM CST
SHA:603883 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,996 | 11,232 | 12,445 | 17,484 | 23,671 | 20,060 | |
Market Cap Growth | -13.03% | -9.75% | -28.82% | -26.14% | 18.00% | -21.42% |
Enterprise Value | 13,130 | 14,500 | 17,004 | 21,848 | 27,905 | 23,899 |
Last Close Price | 14.60 | 14.13 | 15.44 | 20.74 | 27.59 | 25.59 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.67 | 29.41 | 23.98 | 18.82 | 30.16 | 29.97 |
Forward PE | 18.14 | 18.86 | 13.87 | 17.57 | 31.58 | 27.90 |
PS Ratio | 0.49 | 0.51 | 0.56 | 0.78 | 1.17 | 1.28 |
PB Ratio | 1.55 | 1.61 | 1.74 | 2.40 | 3.34 | 4.20 |
P/TBV Ratio | 33.60 | 93.73 | - | 147.68 | 54.13 | 102.21 |
P/FCF Ratio | 3.66 | 3.89 | 8.19 | 8.29 | 11.80 | 11.02 |
P/OCF Ratio | 3.47 | 3.57 | 6.14 | 6.41 | 10.23 | 8.73 |
PEG Ratio | - | 1.01 | 0.58 | 0.86 | 1.33 | 1.47 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.58 | 0.65 | 0.76 | 0.97 | 1.38 | 1.52 |
EV/EBITDA Ratio | 5.14 | 11.48 | 12.12 | 13.14 | 18.20 | 20.56 |
EV/EBIT Ratio | 10.39 | 13.29 | 14.60 | 14.88 | 20.35 | 23.28 |
EV/FCF Ratio | 4.37 | 5.02 | 11.20 | 10.36 | 13.91 | 13.13 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.53 | 0.65 | 0.81 | 0.69 | 0.77 | 1.26 |
Debt / EBITDA Ratio | 1.48 | 1.87 | 2.19 | 1.80 | 2.13 | 2.83 |
Debt / FCF Ratio | 1.25 | 1.58 | 3.81 | 2.39 | 2.72 | 3.31 |
Net Debt / Equity Ratio | 0.23 | 0.31 | 0.47 | 0.42 | 0.43 | 0.96 |
Net Debt / EBITDA Ratio | - | 1.73 | 2.40 | 1.82 | 1.98 | 3.96 |
Net Debt / FCF Ratio | 0.55 | 0.76 | 2.22 | 1.43 | 1.51 | 2.53 |
Asset Turnover | 1.16 | 1.09 | 1.06 | 1.05 | 1.05 | 1.11 |
Inventory Turnover | 4.06 | 4.17 | 3.87 | 3.74 | 4.12 | 4.17 |
Quick Ratio | 0.42 | 0.45 | 0.45 | 0.40 | 0.43 | 0.37 |
Current Ratio | 0.85 | 0.87 | 0.83 | 0.82 | 0.87 | 0.72 |
Return on Equity (ROE) | 8.99% | 7.64% | 9.49% | 15.62% | 16.44% | 16.42% |
Return on Assets (ROA) | 3.97% | 3.33% | 3.44% | 4.31% | 4.47% | 4.54% |
Return on Invested Capital (ROIC) | - | 7.92% | 8.36% | 11.47% | 11.36% | 11.94% |
Return on Capital Employed (ROCE) | - | 11.30% | 11.50% | 14.60% | 13.00% | 12.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.22% | 3.40% | 4.17% | 5.31% | 3.32% | 3.34% |
FCF Yield | 27.30% | 25.72% | 12.21% | 12.06% | 8.47% | 9.07% |
Dividend Yield | 2.83% | 2.77% | 2.51% | 2.21% | 1.23% | 1.11% |
Payout Ratio | 86.44% | 58.82% | 137.56% | 40.33% | 38.49% | 25.14% |
Buyback Yield / Dilution | -1.17% | -0.05% | -1.06% | -0.67% | -6.08% | -2.42% |
Total Shareholder Return | 1.64% | 2.72% | 1.45% | 1.54% | -4.85% | -1.31% |